Meeting
2015 ASCO Annual Meeting
A network meta-analysis-based cost-effectiveness analysis of systematic therapies in advanced pancreatic cancer.
Authors
Kelvin K. Chan
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Kelvin K. Chan , Yoo-Joung Ko , Keya Shah , Kelly Lien , Henry Lam , Doug Coyle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality of Care
Track
Health Services Research and Quality of Care
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 33, 2015 (suppl; abstr 6611)
DOI
10.1200/jco.2015.33.15_suppl.6611
Abstract #
6611
Poster Bd #
168
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.
First Author: Marytere Herrera
Poster
2018 Gastrointestinal Cancers Symposium
Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.
First Author: Erica S Tsang
Poster
2017 Gastrointestinal Cancers Symposium
Evaluation of a cell viability assay based on cultures of CTICs to identify treatment options in third-line pancreatic cancer.
First Author: Mark Ricigliano
Poster
2014 ASCO Annual Meeting
Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study.
First Author: Howard Safran